SEC Comment Letter 0000000000-23-006463 to Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc.
Date: June 15, 2023 · CIK: 0001704287 · Accession: 0000000000-23-006463
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-272432
Letter
United States securities and exchange commission logo June 15, 2023 Neil Dey President and Chief Executive Officer Bluejay Diagnostics, Inc. 360 Massachusetts Avenue, Suite 203 Acton, MA 01720 Re:Bluejay Diagnostics, Inc. Registration Statement on Form S-3 Filed June 5, 2023 File No. 333-272432 Dear Neil Dey: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jordan Nimitz at 202-551-5831 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Brian O'Fahey
Show Raw Text
United States securities and exchange commission logo
June 15, 2023
Neil Dey
President and Chief Executive Officer
Bluejay Diagnostics, Inc.
360 Massachusetts Avenue, Suite 203
Acton, MA 01720
Re:Bluejay Diagnostics, Inc.
Registration Statement on Form S-3
Filed June 5, 2023
File No. 333-272432
Dear Neil Dey:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jordan Nimitz at 202-551-5831 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Brian O'Fahey